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Abstract
Background: ST-elevation myocardial infarction (STEMI) patients have risk factors and co-morbidities and require
procedures predisposing to healthcare acquired infections (HAIs). As few data exist on the extent and
consequences of infections among these patients, the prevalence, predictors, and potential complications of major
infections among hospitalized STEMI patients at all Florida acute care hospitals during 2006 were analyzed.
Methods: Sociodemographic characteristics, risk factors, co-morbidities, procedures, complications, and mortality
were analyzed from hospital discharge data for 11, 879 STEMI patients age ≥18 years. We used multivariable
logistic regression modeling to examine and adjust for multiple potential predictors of any infection, bloodstream
infection (BSI), pneumonia, surgical site infection (SSI), and urinary tract infection (UTI).
Results: There were 2, 562 infections among 16.6% of STEMI patients; 6.2% of patients had ≥2 infections. The most
prevalent HAIs were UTIs (6.0%), pneumonia (4.6%), SSIs (4.1%), and BSIs (2.6%). Women were at 29% greater risk,
Blacks had 23% greater risk, and HAI risk increased 11% with each 5 year increase in age. PCI was the only
protective major procedure (OR 0.81, 95% CI, 0.69-0.95, p < .05). HAI lengthened hospital stays. STEMI patients with
a BSI were almost 5 times more likely (31.3% vs. 6.5%, p < .0001), and those with pneumonia were 3 times more
likely (19.6% vs. 6.5%, p < .0001) to die before discharge.
Conclusions: The protective effect of PCI on risk of infection is likely mediated by its many benefits, including
reduced length of hospitalizations.
Background
Approximately two million health care acquired infec-
tions (HAIs) occur annually (affecting 5-10% of all inpa-
tients and 25% of intensive care unit (ICU) patients),
contributing to an estimated 90, 000 deaths and $4.5 to
$5.7 billion dollars in excess healthcare expenditures
[1,2]. HAI patients average five times the length of stay
(LOS) and treatment cost and six times the in-hospital
mortality versus those without HAIs [3]. Over 80% of
HAIs belong to four categories: urinary tract infection
(UTI) (35% of all infections), surgical site infection (SSI)
(20%), bloodstream infection (BSI) (15%), and pneumo-
nia (15%) [2]. BSIs and pneumonia most significantly
increase mortality [2]. UTIs, despite their prevalence,
result in the lowest additional treatment costs and
excess mortality. Risks of hospital acquired UTI include:
female sex, non-white ethnicity, co-morbidities, unit of
admission, indwelling catheters, invasive procedures, and
mechanical ventilation [4]. Mechanical ventilator use is
also strongly associated with development of pneumonia
[2], while indwelling intravascular catheters, implanted
medical devices, LOS in ICU or surgical ward, and inva-
sive procedures are associated with bacteremias [5].
Few studies have examined predictors of HAIs among
acute myocardial infarction (AMI) patients, especially
ST-elevation myocardial infarction (STEMI) [6]. Among
cardiac care unit (CCU) occupants, pneumonia, BSIs,
and UTIs were strongly associated with invasive device
implantation (i.e. mechanical ventilator, catheter). How-
ever, overall incidence of CCU-acquired HAIs was less
than in other ICUs, attributable to less frequent use of
* Correspondence: mnash@health.usf.edu
1Department of Epidemiology and Biostatistics, College of Public Health,
University of South Florida, (13201 Bruce B. Downs Blvd.), Tampa, (33612),
USA
Full list of author information is available at the end of the article
Nash et al. BMC Cardiovascular Disorders 2011, 11:69
http://www.biomedcentral.com/1471-2261/11/69
© 2011 Nash et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.invasive devices [7]. Reperfusion therapy may cause
HAI, by frequent use of invasive devices and procedures
and procedure-related complications, e.g. contrast-
induced nephropathy. While infrequently utilized for
STEMI patients, surgical revascularization increases the
risk for surgical site infections, pneumonia, and UTIs
[8,9].
To define the prevalence and clinical impact of HAI in
STEMI patients, we examined the prevalence, predictors,
and potential complications of major infections among
hospitalized STEMI patients at all acute care hospitals
in Florida during 2006 (before the October 2007 Medi-
care mandate to report “present on admission” data for
infections), thereby providing baseline population-based
and unselected prevalence data on infections in a high-
risk patient population.
Methods
Study Population and Data Sources
All adults age ≥18 years with a primary diagnosis of
STEMI admitted to non-Veterans Administration acute
care hospitals in 2006 were included. Surveillance data
was obtained from the Florida Agency for Health Care
Administration Hospital Discharge Database, which cap-
tures 100% of hospital discharges. Patient variables ana-
lyzed: age, race/ethnicity, gender, insurance type, type
and source of admission, admitting diagnosis, principal
diagnosis, secondary diagnoses (up to 30 per patient),
procedures (up to 30 per patient), length of stay, and
vital status at discharge. Diagnoses and procedures were
coded using the International Classification of Diseases
(9
th Revision), Clinical Modification (ICD-9-CM). The
University of South Florida IRB granted the study
exempt status.
A total of 14, 148 patient admissions carried a princi-
pal diagnosis of STEMI in 2006, identified by the princi-
pal diagnosis ICD-9-CM codes 410.0 to 410.6 and 410.8,
with a fifth digit of 0 or 1. After excluding transfers (n
= 2, 269), because we could not link separate hospital
records, 11, 879 STEMI patients remained.
Variable Definitions
Infections were identified by secondary diagnosis ICD-9-
CM codes representing conditions listed in CDC/NHSN
surveillance definition of health care-associated infection
and criteria for specific types of infections in the acute
care setting (2008) [10]. We added to a list of HAI ICD-
9-CM codes compiled by Sherman et al. (2006) [11] by
completing our own review of ICD-9-CM infection
codes. Patient risk factors, co-morbidities, and proce-
dures were identified from the thirty ICD-9-CM proce-
dure and secondary diagnosis codes.
Based on CDC surveillance guidelines, we grouped
infection codes into the following categories: (1) BSI, (2)
pneumonia, (3) SSI, (4) UTI, (5) central nervous system
illness, (6) gastrointestinal illness, (7) lower respiratory
tract infection, (8) skin and soft tissue infection, (9)
bone and joint infection, (10) cardiovascular infection,
and (11) ear, eye, nose, and throat infection. Only cate-
gories 1-4 included enough patients to warrant separate
modeling of predictors. Categories 6-11 were collapsed
into an “other infection” group (there were no cases in
category 5), and included patients with secondary diag-
nosis ICD-9-CM codes for site unspecified infections.
Patients with ≥2 infections could be included in more
than one group.
Patient characteristics analyzed were age, sex, race/
ethnicity, and socioeconomic status. Asians/Pacific Islan-
ders, American Indians/Alaskan Natives were grouped
with whites due to their very small numbers. Insurance
type (Medicaid, other state/government, self pay, under-
insured, and charity) was a proxy for low income. Risk
factors analyzed were cigarette smoking, alcohol, and
drug abuse. Our analysis included six serious co-mor-
bidities (chronic bronchitis, COPD, diabetes mellitus,
chronic kidney diseases, cardiomyopathy, and valve dis-
orders), and the following procedures: cardiac catheteri-
zation, percutaneous coronary intervention (PCI),
cardiac surgical procedures, indwelling arterial or
venous catheter, pacemakers and/or implantable defibril-
lators, dialysis, and blood transfusion. Hospital LOS was
the total number of days between admission and dis-
charge. ICU or CCU stay was a dichotomous variable
(yes/no) based on the presence or absence of ICU/CCU
financial charges in the discharge record.
Statistical Analyses
We evaluated the proportion of STEMI patients with
any infection and for each category, along with the total
number of infections present and the prevalence of mul-
tiple infections. We used multivariable logistic regres-
sion modeling to examine and adjust for multiple
potential predictors of any infection, BSI, pneumonia,
SSI, and UTI. The 9, 910 patients with no diagnosed
infection comprised the comparison group for all
models.
Several important co-morbidities (acute renal failure,
heart failure), procedures (mechanical ventilation, Swan-
Ganz catheter), and outcomes (admission to the ICU/
CCU, hospital LOS), important potential complications
of infection, were not included in the predictive models
because the temporal relationship to the onset of infec-
tion could not be determined, e.g. whether ICU stay
resulted in or was a consequence of an infection. The
prevalence of each potential infectious complication was
compared to the prevalence among non-infected
patients using a chi-square test of homogeneity. The in-
hospital mortality for each infection group was
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SAS version 9.1.3 (SAS Institute, Cary, North Carolina)
for all analyses.
Results
There were 2, 562 infections among 1, 969 (16.6%)
STEMI patients; 739 (6.2%) patients had ≥2 infections.
UTIs (6.0%) were most prevalent, followed by pneumo-
nia (4.6%), SSIs (4.1%), and BSIs (2.6%). Their relative
frequencies were 36.1%, 27.7%, 24.7%, and 15.7%,
respectively. Lower respiratory tract, cardiovascular,
bone and joint, eye, ear, nose, and throat, gastrointest-
inal, skin and soft tissue, and non-specific bacterial
infections (other infection) comprised 4.2% of patients
(Table 1). Thirty-seven (0.3%) patients had an intra-car-
diac or pericardial infection. Overall, STEMI patients
were older, more likely to be white and male, and a
nearly one-third smoked (28.9%) and had diabetes
(27.1%). The most common procedure was cardiac
catheterization (66.9%), followed by PCI (59.0%).
Infected patients were older, less likely to be smokers
and receive PCI, and had more co-morbidities than
patients with no infection (Table 2). The majority of
infected STEMI patients underwent at least one minor
or major procedure.
After multivariable adjustment, all other risk factors
and co-morbidities examined were associated with
increased risk of infection, except for cigarette smoking
(OR 0.76, 95% CI 0.66-0.87, p < .01) (Table 3). Women
and Blacks had a 29% and 23% greater risk, respectively,
while the risk of infection increased 11% with each 5 year
increase in age. Most procedures conveyed an increased
risk - the notable exception was the lower risk associated
with PCI (OR 0.81, 95% CI, 0.69-0.95, p < .01).
Bloodstream Infections
BSIs were the most serious but least common type of
HAI (Table 3). Valve disease (OR 2.22, 95% CI 1.26-
3.92, p < .01) and COPD (OR 1.80, 95% CI 1.03-3.14, p
< .05) conveyed particular risk. A trend toward elevated
prevalence was observed among Hispanics, older
patients, and those with chronic kidney diseases (includ-
ing ESRD) (p = n.s.). Procedures with the strongest
association were an indwelling arterial or venous cathe-
ter (OR 6.99, 95% CI 3.93-12.41, p < .0001), dialysis (OR
6.97, 95% CI 2.81-17.26, p < .0001), and blood transfu-
sion (OR 2.10, 95% 1.07-4.11, p < .05). BSI sufferers
were more likely than non-infected patients to develop
acute renal failure (51.3% vs. 5.3%, p < .0001) or heart
failure (58.8% vs. 18.0%, p < .0001), and were almost 5
times as likely to die before discharge (31.3% vs. 6.5%, p
< .0001) (Table 4).
Pneumonia
Pneumonia risk increased with alcohol abuse (OR 2.31,
95% CI 1.33-4.01, p < .01), chronic bronchitis (OR 4.30,
95% CI 2.82-6.56, p < .0001), and COPD (OR 2.28, 95%
CI 1.75-2.96, p < .0001), but not with sociodemographic
characteristics (Table 3). Indwelling intravascular cathe-
ters (OR 3.93, 95% CI 2.79-5.55, p < .0001), dialysis (OR
3.55, 95% CI 1.76-7.09, p < .01), and cardiac surgical
procedures (OR 1.54, 95% CI 1.02-2.33, p < .05) were
associated with an increased risk. Although mechanical
ventilation has been reported to convey a strong risk for
development of pneumonia, [12] only 13.1% of the
STEMI patients with pneumonia were ventilated during
their hospital stay (Table 4). Pneumonia was compli-
cated more frequently by acute renal failure (30.6% vs.
5.3%, p < .0001), heart failure (63.5% vs. 18.0%, p <
.0001), and patients were 3 times as likely to in-hospital
(19.6% vs. 6.5%, p < .0001).
Surgical Site Infections
Cardiac catheterization (OR 2.89, 95% CI 1.98-4.22, p <
.0001) was the strongest predictor of SSI, followed by
dialysis (OR 2.61, 95% CI 1.10-6.17, p < .05), indwelling
intravascular catheters (OR 1.98, 95% CI 1.30-3.03, p <
.05), and blood transfusion (OR 1.62, 95% CI 1.08-2.45,
p < .05). However, PCI was associated with a lower risk
of SSI (OR 0.63, 95% CI 0.46-0.88, p < .01). Except for
the lower risk of infection associated with cigarette
smoking (OR 0.70, 95% CI 0.53-0.91, p < .01), co-mor-
bidities and risk factors did not impact risk of SSI. We
Table 1 Infections among hospitalized STEMI patients
(n = 11, 879)* in Florida, 2006.
Infection Categories
† Frequency of Infection
‡ % (n)
Infected STEMI Patients 16.6 (1, 969)
Blood Stream Infection (BSI) 2.6 (310)
Any additional infection 75.0 (233)
No additional infection 25.0 (77)
Pneumonia 4.6 (550)
Any additional infection 41.0 (224)
No additional infection 59.0 (326)
Surgical Site Infection (SSI) 4.1 (491)
Any additional infection 30.0 (145)
No additional infection 70.0 (346)
Urinary Tract Infection (UTI) 6.0 (708)
Any additional infection 35.0 (248)
No additional infection 65.0 (460)
All Other Infections
§ 4.2 (503)
*Excludes patients who were transferred to another hospital.
†Patients can appear in more than one infection category.
‡There were a total of 2, 562 infections.
§Includes lower respiratory, gastrointestinal, cardiovascular, bone and joint,
and ear, eye, nose & throat, skin and soft tissue, and site unspecified bacterial
infections.
Nash et al. BMC Cardiovascular Disorders 2011, 11:69
http://www.biomedcentral.com/1471-2261/11/69
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All STEMI
Patients
n = 11, 879
% (n)
Non-Infected
STEMI Patients
n = 9, 910
% (n)
Blood Stream
Infection
†
n = 310
% (n)
Pneumonia
n = 550
% (n)
Surgical Site
Infection
n = 491
% (n)
Urinary Tract
Infection
n = 708
% (n)
All Other
Infections
‡
n = 503
% (n)
Patient
Sociodemographic
Characteristics^
Age
Age 18-34 Years 0.9 (107) 1.0 (100) No cases** No cases** 0.6 (3) ‡‡ 0.3 (2)** 0.8 (4)**
Age 35-44 Years 6.2 (735) 6.6 (658) 4.9 (15) 2.4 (13) 5.9 (29) 1.4 (10) 6.4 (32)
Age 45-54 Years 18.7 (3057) 20.0 (1984) 10.1 (31) 3.6 (47) 20.6 (101) 5.4 (38) 14.5 (73)
Age 55-64 Years 23.9 (2837) 24.9 (2471) 19.5 (60) 19.6 (108) 22.8 (112) 14.0 (99) 19.7 (99)
Age 65-74 Years 21.7 (2573) 21.4 (2116) 24.7 (76) 24.9 (137) 25.3 (124) 21.2 (150) 22.3 (112)
Age 75-84 Years 18.5 (2196) 17.0 (1680) 26.3 (81) 28.0 (154) 19.1 (94) 34.0 (241) 23.7 (119)
Age 85+ Years 10.2 (1216) 9.1 (901) 14.6 (45) 16.6 (91) 5.7 (28) 23.7 (168) 12.7 (64)
Sex
Female 33.7 (4001) 31.8 (3149) 38.6 (119) †† 38.6 (212)
††
30.4 (149) 59.5 (421)** 42.9 (216)**
Male 66.3 (7878) 68.2 (6761) 61.4 (189) 61.5 (338) 69.7 (342) 40.5 (287) 57.1 (287)
Race/Ethnicity
White 83.1 (9868) 83.3 (8256) 78.3 (241) 81.8 (450) 81.5 (400) 82.2 (582) 82.3 (414)
Black 6.7 (798) 6.5 (640) 9.1 (28) 7.6 (52) 9.2 (45) 8.2 (58) 7.4 (37)
Hispanic 10.2 (1213) 10.2 (1014) 12.7 (39) 10.6 (58) 9.4 (46) 9.6 (68) 10.3 (52)
Income by Proxy
Low income (Medicaid,
self-pay,
uninsured)
16.7 (1979) 17.3 (1711) 13.0 (40) ‡‡ 10.6 (58)** 19.6 (96) 9.5 (67)** 15.9 (80)
All other insurance
§ 83.3 (9900) 82.7 (8199) 87.0 (268) 89.5 (492) 80.5 (395) 90.5 (641) 84.1 (423)
Patient Risk Factors
Cigarette smoking 28.9 (3430) 30.6 (3030) 14.9 (46)** 22.4 (123)** 24.4 (120) †† 12.0 (85)** 23.7 (119) ††
Alcohol abuse 3.0 (352) 2.8 (273) 4.6 (14) 5.3 (29) †† 4.9 (24) †† 2.0 (14) 5.8 (29)**
Drug abuse 2.4 (287) 2.4 (237) 2.3 (7) 2.2 (12) 3.3 (16) 1.6 (11) 4.2 (21) ‡‡
Patient Co-Morbidities
Chronic bronchitis 2.7 (317) 2.2 (213) 6.8 (21)** 10.0 (55)** 4.3 (21) †† 5.1 (36)** 4.0 (20) ††
Chronic obstructive
pulmonary
disease (COPD)
16.2 (1921) 14.0 (1382) 28.3 (87)** 30.7 (169)** 20.8 (102)** 24.0 (170)** 37.0 (186)**
Diabetes 27.1 (3222) 25.5 (2527) 35.1 (108) §§ 34.2 (188)** 32.4 (159) †† 38.6 (273)** 37.2 (187)**
Chronic kidney diseases
|
|
9.6 (1145) 7.7 (764) 29.9 (92)** 22.7 (125)** 13.4 (66)** 23.2 (164)** 17.1 (86)**
Cardiomyopathy 6.3 (755) 5.5 (546) 16.9 (52)** 12.7 (70)** 9.8 (48)** 11.0 (78)** 11.9 (60)**
Valve disorders 10.1 (1203) 9.1 (902) 21.4 (66)** 16.0 (88)** 11.8 (58) ‡‡ 16.2 (115)** 17.9 (90)**
Patient Procedures
Cardiac catheterization 66.9 (7941) 67.7 (6710) 59.4 (184) †† 57.1 (314)** 80.7 (396)** 54.2 (384)** 65.4 (329)
Percutaneous coronary
intervention
(PCI)
59.0 (7009) 61.2 (6065) 41.6 (128)** 44.0 (242)** 62.1 (305) 41.0 (290)** 47.9 (241)**
Cardiac surgical
procedures
9.8 (1168) 8.4 (830) 24.4 (75)** 18.6 (102)** 19.4 (95)** 16.4 (116)** 24.1 (121)**
Indwelling arterial or
venous
catheter
6.0 (707) 3.6 (360) 45.2 (140)** 26.6 (146)** 18.1 (89)** 18.9 (134)** 20.9 (105)**
Pacemaker
# 2.3 (275) 2.1 (210) 3.6 (11) 4.2 (23) †† 4.9 (24)** 2.3 (16) 3.6 (18) ‡‡
Dialysis 1.5 (172) 0.7 (68) 16.5 (51)** 6.9 (38)** 6.5 (32)** 5.1 (36)** 6.6 (33)**
Blood transfusion 6.7 (800) 5.1 (507) 26.6 (82)** 15.3 (84)** 15.3 (75)** 17.5 (124)** 15.5 (78)**
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risk of SSI among Black and low income patients. Over-
all, the prevalence of potential complications of SSIs was
lower than for BSIs and pneumonia (Table 4), although
these patients were almost 4 times more likely to be
mechanically ventilated than non-infected patients
(21.2% vs. 5.4%, p < .0001). In-hospital mortality was
21% more likely among these patients (7.9% vs. 6.5%, p
= n.s.).
Urinary Tract Infections
UTI, the most common infection complicating STEMI,
occurred in women more frequently than men (OR
2.46, 95% CI 1.99-3.03, p < .0001) (Table 3). Each 5-year
increase in patient age increased its risk by 27% (OR
1.27, 95% CI 1.21-1.33, p < .0001). Co-morbidities and
procedures associated with a higher prevalence of UTIs
were: chronic kidney disease (OR 1.64, 95% CI 1.26-
2.14, p < .01), diabetes (OR 1.59, 95% CI 1.30-1.96, p <
.0001), COPD (OR 1.57, 95% CI 1.24-2.00, p < .01), dia-
lysis (OR 2.24, 95% CI 1.19-4.19, p < .05), blood transfu-
sion (OR 1.94, 95% CI 1.43-2.64, p < .0001), cardiac
surgical procedures (OR 1.83, 95% CI 1.28-2.62, p <
.01), and an indwelling intravascular catheter (OR 1.69,
95% CI 1.17-2.43, p < .01). UTI patients had a much
higher prevalence of acute renal failure (28.8% vs. 5.3%,
p < .0001) and heart failure (50.6% vs. 18.0%, p < .0001),
and had a 69% higher risk of in-hospital death (11.0%
vs. 6.5%, p < .0001) (Table 4).
Discussion
Our study revealed that 16.6% of STEMI patients hospi-
talized in Florida experienced HAI, approaching the
20.6% prevalence for ICU-acquired infections reported
b yV i n c e n te ta l .[ 1 3 ]a n do v e rt h r e et i m e st h e5 %r a t e
reported in studies of AMI [14] and CCU patients
[7,15]. Consistent with ICU patients with nosocomial
infections [13,16], infected STEMI patients experienced
prolonged hospital stays and were more likely to die
prior to discharge. After multivariable adjustment,
important factors associated with infection included
older age, female gender, Black race, alcohol or drug
use, and several serious co-morbidities. Older age,
female gender, diabetes, and chronic kidney diseases
were all strongly associated with the risk of UTI, consis-
tent with an increased prevalence of asymptomatic bac-
teriuria and UTIs reported in elderly women with those
comorbidities [17]. Urinary tract catheterization can
potentiate the risk for serious and potentially life threa-
tening UTIs in these patients.
Cigarette smoking was associated with a lower risk of
HAI, despite well-known deleterious actions of cigarette
smoke [18]. A possible explanation is that AMI patients
who smoke tend to be youngert h a nn o n - s m o k e r sa n d
may possess fewer comorbidities, reducing their likeli-
hood of infection [19]. This observed lower risk of infec-
tion in smokers may contribute to the reduced mortality
rates reported by us [20] and others [21], especially
since the majority of STEMI patients who smoked were
younger than those who did not smoke.
Major procedures, especially dialysis, cardiac surgical
procedures, blood transfusions, and indwelling arterial
or venous catheters were associated with a higher preva-
lence of infection. While insertion, catheter number,
and implantation duration of indwelling catheters
increase the risk of both insertion site and systemic
infections, catheter use is also a marker of the severity
of the patient’s underlying condition.
Significantly, PCI was found to be associated with a
much lower risk of HAI, particularly SSI. In contrast,
cardiac catheterization was associated with an increased
risk of SSI. While the risk of infection due to both car-
diac catheterization and PCI is low (< 1%), a greater risk
occurs with PCI, especially when complicated [22,23].
This paradoxical effect may be explained by cardiac
catheterization being a surrogate marker for other HAI-
increasing procedures, e.g. cardiac surgical procedures,
or the complications related to non-reperfusion therapy.
Only 4.2% of the total cohort received thrombolysis.
Demographic and comorbid factors could confound the
association of catheterization with HAI, e.g. approxi-
mately 64% of those not receiving catheterization were
≥65 years old compared to 42% of those who did, and
all analyzed co-morbidities occurred slightly more
Table 2 Characteristics of hospitalized STEMI patients (n = 11, 879)* by infection status, Florida 2006. (Continued)
Patients with none of
the above
procedures
26.7 (3169) 26.5 (2630) 21.0 (65) ‡‡ 30.4 (167)
‡‡
11.0 (54)** 34.9 (247)** 23.9 (120)
*Excludes patients who were transferred to another hospital.
** p < .0001; †† p < .01; ‡‡ p < .05; §§ p = .0001
†Patients can appear in more than one infection category.
‡Includes lower respiratory, gastrointestinal, cardiovascular, bone and joint, ear, eye, nose & throat, skin and soft tissue, and site unspecified bacterial infections.
§Includes Medicare, commercial insurance, worker’s compensation, CHAMPUS, VA, and unspecified.
| |Includes hypertensive chronic kidney disease, end-stage renal disease (ESRD), unspecified chronic kidney disease and unspecified chronic renal failure.
#Includes temporary/permanent pacemakers and implantable defibrillators.
^Chi-square tests of homogeneity were conducted to compare patient characteristics for each infection to non-infected STEMI patients (excluding all patients).
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patients. These differences were addressed in the regres-
sion analysis. Thus, the lower risk associated with PCI
could reflect the over-riding benefit of this STEMI
treatment. PCI patients suffer less myocardial damage,
resulting in improved hemodynamic and clinical states,
leading to shorter ICU/CCU stays and earlier hospital
discharge, contributing to reduced HAI exposure.
Table 3 Multivariable adjusted odds ratios for predictors of infection among STEMI Patients (n = 11, 879)*,
† at acute
care hospitals in Florida, 2006.
All Infections
n = 1, 969
Odds-Ratio (95%
CI)
Blood Stream
Infection
3
n = 310
Odds Ratio (95% CI)
Pneumonia
‡
n = 550
Odds Ratio (95%
CI)
Surgical Site
Infection
‡
n = 491
Odds Ratio (95%
CI)
Urinary Tract
Infection
‡
n = 708
Odds Ratio (95%
CI)
Patient Characteristics
Age
Each 5 year increase 1.11 (1.00 - 1.14)
‡‡
1.06 (0.95 - 1.17) 1.21 (0.14 - 1.28) 0.99 (0.94 - 1.04) 1.27 (1.21 - 1.33)**
Sex
Female 1.29 (1.15 - 1.44)** 0.71 (0.43 - 1.21) 0.83 (0.64 - 1.06) 0.80 (0.62 - 1.04) 2.46 (1.99 - 3.03)**
Race/Ethnicity
Black race 1.23 (1.00 - 1.51)
‡‡
1.27 (0.54 - 2.97) 1.19 (0.75 - 1.90) 1.44 (0.98 - 2.11) 1.01 (0.67 - 1.52)
Hispanic ethnicity 1.05 (0.88 - 1.25) 1.92 (0.99 - 3.73) 0.98 (0.65 - 1.47) 0.84 (0.57 - 1.22) 1.02 (0.70 - 1.42)
Income by Proxy
Low income (Medicaid, self-pay,
uninsured)
1.14 (0.97 - 1.34) 1.36 (0.69 - 2.71) 1.07 (0.73 - 1.58) 1.30 (0.97 - 1.73) 1.13 (0.78 - 1.64)
Patient Risk Factors
Cigarette smoking 0.76 (0.66 - 0.87)
††
0.62 (0.32 - 1.22) 1.16 (0.86 - 1.56) 0.70 (0.53 - 0.91) †† 0.66 (0.48 - 0.82) ‡‡
Alcohol abuse 1.73 (1.30 - 2.31)
††
0.94 (0.20 - 4.44) 2.31 (1.33 - .01) †† 1.67 (0.96 - 2.90) 0.93 (0.37 - 2.36)
Drug abuse 1.55 (1.09 - 2.20)
‡‡
1.80 (0.37 - 8.80) 0.64 (0.22 - 1.84) 1.02 (0.52 - 2.00) 1.38 (0.48 - 3.84)
Patient Co-Morbidities
Chronic bronchitis 2.39 (1.84 - 3.09)** 2.56 (0.87 - 7.52) 4.30 (2.82 - .56)** 1.17 (0.54 - 2.53) 1.47 (0.85 - 2.53)
Chronic obstructive pulmonary disease
(COPD)
2.03 (1.79 - 2.30)** 1.80 (1.03 - 3.14) ‡‡ 2.28 (1.75 - .96)** 1.22 (0.90 - 1.65) 1.57 (1.24 - 2.00) ††
Diabetes 1.33 (1.19 - 1.49)** 0.94 (0.56 - 1.58) 1.10 (0.85 - 1.42) 1.24 (0.98 - 1.58) 1.59 (1.30 - 1.96)**
Chronic Kidney Diseases
§ 1.47 (1.26 - 1.72)** 1.72 (0.92 - 3.23) 1.43 (1.04 - .98) ‡‡ 0.85 (0.54 - 1.32) 1.64 (1.26 - 2.14) ††
Cardiomyopathy 1.50 (1.25 - 1.80)** 1.55 (0.75 - 3.22) 1.20 (0.80 - 1.81) 1.24 (0.81 - 1.91) 1.26 (0.89 - 1.71)
Valve disorders 1.17 (1.01 - 1.37)
‡‡
2.22 (1.26 - 3.92) †† 1.22 (0.88 - 1.68) 0.94 (0.64 - 1.39) 0.91 (0.69 - 1.22)
Patient Procedures
Cardiac catheterization 1.10 (0.93 - 1.30) 0.51 (0.25 - 1.04) 0.79 (0.55 - 1.15) 2.89 (1.98 - 4.22)** 1.07 (0.77 - 1.47)
Percutaneous coronary intervention
(PCI)
0.81 (0.69 - 0.95)
††
1.05 (0.53 - 2.08) 0.85 (0.59 - 1.21) 0.63 (0.46 - 0.88) †† 0.85 (0.63 - 1.16)
Cardiac surgical procedures 1.53 (1.28 - 1.84)** 1.42 (0.65 - 3.14) 1.54 (1.02 - .33)# 0.66 (0.43 - 1.01) 1.83 (1.28 - 2.62) ††
Indwelling arterial or venous catheter 3.90 (3.29 - 4.63)** 6.99 (3.93 - 12.41)** 3.93 (2.79 - .55)** 1.98 (1.30 - 3.03) †† 1.69 (1.17 - 2.43) ††
Pacemaker
|| 1.02 (0.74 - 1.40) 0.63 (0.14 - 2.80) 1.41 (0.76 - 2.58) 1.43 (0.79 - 2.57) 0.61 (0.30 - 1.23)
Dialysis 3.40 (2.40 - 4.82)** 6.97 (2.81 - 17.26)** 3.55 (1.76 - .09) †† 2.61 (1.10 - .17) ‡‡ 2.24 (1.19 - 4.19) ‡‡
Blood Transfusion 1.64 (1.37 - 1.96)** 2.10 (1.07 - 4.11) ‡‡ 0.90 (0.58 - 1.40) 1.62 (1.08 - .45) ‡‡ 1.94 (1.43 - 2.64)**
*Excludes patients who were transferred to another hospital.
** p < .0001; †† p < .01; ‡‡ p < .05; §§ p = .0001
†All models compared to non-infected STEMI patients and are adjusted for all other variables in the table.
‡Patients can appear in more than one infection category.
§Includes hypertensive chronic kidney disease, end-stage renal disease (ESRD), unspecified chronic kidney disease and unspecified chronic renal failure.
| |Includes temporary/permanent pacemakers and implantable defibrillators.
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Limitations of our study include the potential for mis-
classification of both secondary diagnosis and proce-
dures codes. Sherman et al. reported that administrative
data reviews were not as accurate as targeted active sur-
veillance at identifying HAIs [11]. Major procedures per-
formed in surgical wards are likely to be correctly ICD-
9-CM coded; however, minor procedures performed in
patients’ rooms or in radiology departments are often
inaccurately coded or missing [24]. Consequently, we
could not evaluate the prevalence of indwelling urinary
catheters, a minor procedure rarely reported. In our
2006 dataset, “present on admission” indicator variables
were incomplete and could not be analyzed. These cod-
ing inaccuracies may persist, because as of October
2007 Medicare no longer reimburses hospitals for treat-
ment costs incurred by HAIs [25]. Thus, the prevalence
of HAIs is likely underestimated.
Our study could not definitively establish a temporal
association among co-morbidities, procedures, and
development of infections. This limitation should be
addressed in future studies with more detailed clinical
data, preferably by medical chart review. However, even
with chart review, temporality may often be difficult to
establish, because the detailed physical exams and multi-
ple tissue cultures necessary to establish “present on
admission” infections may not routinely be completed
for STEMI patients in many hospitals. This limitation
particularly applies to UTIs, which are not rare in com-
munity-dwelling populations and are often asympto-
matic in elderly women [17], but is less problematic
than for other types of infections. Finally, any selection
biases of patients for PCI and the relationship of the
timing of PCI to admission could not be determined.
Conclusions
We conclude that: 1) Approximately one sixth of
STEMI patients hospitalized in Florida develop an HAI,
a prevalence rate approaching that for ICU patients,
often resulting in prolonged hospital stays and adverse
clinical outcomes including in-hospital mortality; 2) BSIs
and pneumonia were associated with the greatest likeli-
hood of prolongation of hospital stay and in-hospital
mortality; and 3) PCI was associated with reduced risk
of overall infection, especially SSI. While current STEMI
treatment guidelines do not emphasize risk of HAI
[26,27], improved surveillance, prevention, and treat-
ment for high risk patients may reduce the risk. Despite
limitations inherent in this type of study, the lower risk
of infection associated with PCI provides additional sup-
port for the use of primary PCI for STEMI therapy.
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Table 4 Potential complications of infection among hospitalized STEMI patients (n = 11, 879)* in Florida, 2006.
Non-Infected STEMI
Patients
n = 9, 910
% (n)
Blood Stream
Infection
n = 310
†
% (n)
Pneumonia
n = 550
% (n)
Surgical Site
Infection
n = 491
% (n)
Urinary Tract
Infection
n = 708
% (n)
All Other
Infections
n = 503
‡
% (n)
Potential Complications of
Infection
§
Acute renal failure 5.3 (526) 51.3 (158)** 30.6 (168)** 15.5 (76)** 28.8 (204)** 23.1 (116)**
Heart failure 18.0 (1776) 58.8 (181)** 63.5 (349)** 26.9 (132)** 50.6 (358)** 46.9 (236)**
Swan-Ganz catheter 1.3 (129) 8.8 (27)** 5.1 (28)** 3.9 (19)** 4.0 (28)** 5.0 (25)**
Mechanical ventilation 5.4 (537) 14.9 (46)** 13.1 (72)** 21.2 (104)** 8.5 (60)** 25.1 (126)**
Intensive care unit stay 64.0 (6339) 69.8 (215) ‡‡ 69.3 (381)
‡‡
68.2 (335) ‡‡ 70.6 (500)^ 67.8 (341)
Length of stay 7+ days 15.5 (1535) 75.7 (233)** 65.5 (360)** 44.8 (220)** 57.6 (408)** 61.6 (310)**
In-hospital mortality 6.5 (640) 31.3 (97)** 19.6 (108)** 7.9 (39) 11.0 (78)** 7.4 (37)
* Excludes patients who were transferred to another hospital.
** p < .0001; †† p < .01; ‡‡ p < .05; §§ p = .0001
† Patients can appear in more than one infection category.
‡ Includes lower respiratory, gastrointestinal, cardiovascular, bone and joint, ear, eye, nose & throat, skin and soft tissue, and site unspecified bacterial infections.
§ Chi-square tests of homogeneity were conducted to compare potential complicating factors of each infection to non-infected STEMI patients.
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